购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Acyltransferase
    (1)
  • Drug Metabolite
    (1)
  • Epigenetic Reader Domain
    (1)
  • IRE1
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (2)
  • 6-8周
    (2)
  • 8-10周
    (1)
  • 10-14周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "glucose intolerance"的结果
筛选
搜索结果
TargetMol产品目录中 "

glucose intolerance

"的结果
  • 抑制剂&激动剂
    8
    TargetMol | Inhibitors_Agonists
  • 天然产物
    1
    TargetMol | Natural_Products
  • Sequoyitol
    红杉醇,西曲依醇, 红杉醇, 5-O-Methyl-Myo-Inositol
    TMS0719523-92-2
    Sequoyitol (5-O-Methyl-Myo-Inositol) 来源于植物。它可以改善体内葡萄糖耐量,降低血糖,可用于糖尿病的研究。
    • ¥ 335
    In stock
    规格
    数量
  • Exicorilant
    CORT 125281
    T152641781244-77-6
    Exicorilant is a selective and oral active glucocorticoid receptor (GR) antagonist (Ki: 7 nM) and it also has the potential to overcome adiposity, glucose intolerance, and dyslipidemia.
    • ¥ 16100
    3-6月
    规格
    数量
  • JTT-553
    T207690701232-94-2
    JTT-553 是一种 DGAT1 抑制剂 (IC50: 2.38 nM)。它可降低血浆中葡萄糖、胰岛素、非酯化脂肪酸 (NEFA)、总胆固醇 (TC) 和肝脏甘油三酯 (TG) 的浓度。在 DIO 小鼠中,JTT-553 改善了脂肪组织中胰岛素依赖性葡萄糖的摄取和葡萄糖不耐受的问题。此外,JTT-553 在 KK-Ay 小鼠中降低脂肪组织中的 TNF-α mRNA 水平,并提高 GLUT4 mRNA 的水平。通过减轻体重,JTT-553 改善了胰岛素抵抗和全身葡萄糖代谢。JTT-553 可用于研究肥胖症及 2 型糖尿病 (T2DM)。
    • 待询
    10-14周
    规格
    数量
  • BDM44768
    BDM 44768,BDM-44768
    T251422011754-00-8
    BDM44768 is an insulin-degrading enzyme (IDE) inhibitor that acts by inducing glucose intolerance.
    • ¥ 10600
    6-8周
    规格
    数量
  • T-1095A
    T 1095A, J1.265.331J
    T28897209746-56-5
    T-1095A is an active metabolite of T-1095, a potent and selective inhibitor of Na+-glucose cotransporters (SGLTs). Chronic administration of T-1095 (0.1% w w(-1) pellet chow, for 12 weeks) decreased blood glucose and haemoglobin A(1C) levels, and improved
    • ¥ 10600
    6-8周
    规格
    数量
  • CPT-157633
    T41018888213-72-7
    CPT-157633 is a difluoro-phosphonomethyl phenylalanine derivative that acts as a potent inhibitor of the enzyme PTP1B. It effectively prevents the development of glucose intolerance induced by binge drinking.
    5日内发货
    询价
  • DS-1558
    T712511202575-67-4
    DS-1558 is a potent and orally available GPR40 agonist.DS-1558 was found to have potent glucose lowering effects during an oral glucose tolerance test in ZDF rats. DS-1558 significantly and dose-dependently improved hyperglycemia and increased insulin secretion during the oral glucose tolerance test in Zucker fatty rats, the model of insulin resistance and glucose intolerance. DS-1558 not only increased the glucose-stimulated insulin secretion by GLP-1 but also potentiated the maximum insulinogenic effects of GLP-1 after an intravenous glucose injection in normal Sprague Dawley rats.
    • ¥ 13900
    8-10周
    规格
    数量
  • ATF3 inducer 1
    ATF3 诱导剂 1
    T829523038756-30-5
    ATF3 inducer 1 是一种高效 ATF3 诱导剂,具有降脂特性和抗高血糖活性,能减轻 HFD 诱导的葡萄糖耐量异常和胰岛素抵抗,缓解 HFD 引发的肝脏脂肪变性,可用于研究肥胖。
    • ¥ 979
    In stock
    规格
    数量
没有更多数据了